Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Antifungals Industry By 2029?

The market size of antifungals has shown robust growth in the past few years. Expectations are that it will expand from $27.16 billion in 2024 to $29.6 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.0%. The substantial growth witnessed during the historical period can be credited to the prevalence of fungal diseases, the rise in the elderly population, the development of healthcare infrastructure, and increased awareness and education.

The market size of antifungals is projected to experience significant growth in the coming years. It is expected to reach ” $41.2 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. This growth in the forecast period can be ascribed to factors such as the emergence of new fungal strains, regulatory approval processes, global health worries, augmented spending on healthcare, as well as the education and awareness of patients. Notable trends shaping the forecast period include the advancement of antifungal drug research and improvements, a focus on e-health and telemedicine, along with collaborations and strategic partnerships.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp

What Growth-Enabling Forces Are Impacting The Antifungals Market?

The antifungals market is predicted to grow as a result of the rising prevalence of fungal infections. These infections are created by the infiltration and proliferation of fungi either inside or on the surface of the body, affecting organs such as the skin, nails, lungs, and mucous membranes. The increased occurrence of these infections can be attributed to various factors, including a rise in immunocompromised individuals, conditions conducive to fungal growth due to climate change, disruption of natural microbiomes through the overuse of broad-spectrum antibiotics, insufficient hygiene, urbanization, and a surge in chronic diseases like diabetes which make people more susceptible to such infections. Antifungals have a crucial part in treating fungal diseases by curbing the fungi’s growth and reproduction. This is generally done by either disrupting the fungi’s cell wall or membrane, blocking vital enzymatic processes, or hindering their ability to concoct essential components thereby lowering fungal load, calming symptoms, and preventing the infection from spreading inside the body. For example, the US-based not-for-profit organization International Society For Infectious Diseases recorded an annual incident rate of 6.5 million invasive fungal infections in September 2024. These were associated with roughly 3.8 million fatalities, of which 2.5 million (68%, with a range of 35-90%) were linked directly to the infections. Consequently, the increasing incidence of these infections is likely to stimulate the antifungals market.

Which Segment Accounts For The Largest Share In The Antifungals Market?

The antifungals market covered in this report is segmented –

1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines

2) By Route of Administration: Oral, Parenteral, Topical

3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users

Subsegments:

1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin

2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Ketoconazole

3) By Polyenes: Amphotericin B, Nystatin

4) By Allylamines: Terbinafine, Naftifine

Which Long-Term Trends Will Play A Crucial Role In The Antifungals Market?

Pharmaceutical companies involved in the creation and production of drugs are enhancing numerous areas of their operation, including research and development, marketing, and production, by joining forces with other businesses and research institutions in order to diversify their range of products. Hence, firms operating in the anti-infective drugs sector should contemplate strategic partnerships as a means to widen their reach, diversify their product range, increase earnings and remain competitive in the market.

Which Companies Hold A Competitive Edge In The 503 Market?

Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Which Region Is Forecasted To Lead The Antifungals Market In The Coming Years?

North America was the largest region in the drugs for antifungals market in 2024. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2442&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model